Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons

Overview

Journal J Innate Immun

Publisher Karger

Specialty Allergy & Immunology

Date 2016 Jul 18

PMID 27423203

Citations 40

Authors

Spyridon Makris

Monika Bajorek

Fiona J Culley

Michelle Goritzka

Cecilia Johansson

Affiliations

Soon will be listed here.

Abstract

Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract infections. Immunity to RSV is initiated upon detection of the virus by pattern recognition receptors, such as RIG-I-like receptors. RIG-I-like receptors signal via MAVS to induce the synthesis of proinflammatory mediators, including type I interferons (IFNs), which trigger and shape antiviral responses and protect cells from infection. Alveolar macrophages (AMs) are amongst the first cells to encounter invading viruses and the ones producing type I IFNs. However, it is unclear whether IFNs act to prevent AMs from serving as vehicles for viral replication. In this study, primary AMs from MAVS (Mavs-/-)- or type I IFN receptor (Ifnar1-/-)-deficient mice were exposed to RSV ex vivo. Wild-type (wt) AMs but not Mavs-/- and Ifnar1-/- AMs produced inflammatory mediators in response to RSV. Furthermore, Mavs-/- and Ifnar1-/- AMs accumulated more RSV proteins than wt AMs, but the infection was abortive. Thus, RIG-I-like receptor-MAVS and IFNAR signalling are important for the induction of proinflammatory mediators from AMs upon RSV infection, but this signalling is not central for controlling viral replication. The ability to restrict viral replication makes AMs ideal sensors of RSV infection and important initiators of immune responses in the lung.

Citing Articles

Enhanced Pathogenic Consequences Induced by a Seven-Amino-Acid Extension in the G Protein of the HRSV BA9 Genotype.

Wang N, Song J, Cao L, Mao N, Shi Y, Jiang J Int J Mol Sci. 2025; 26(5).

PMID: 40076707 PMC: 11900327. DOI: 10.3390/ijms26052081.

Alveolar Macrophages in Viral Respiratory Infections: Sentinels and Saboteurs of Lung Defense.

Popperl P, Stoff M, Beineke A Int J Mol Sci. 2025; 26(1.

PMID: 39796262 PMC: 11721917. DOI: 10.3390/ijms26010407.

Analysis of Beyfortus (Nirsevimab) Immunization Campaign: Effectiveness, Biases, and ADE Risks in RSV Prevention.

Banoun H Curr Issues Mol Biol. 2024; 46(9):10369-10395.

PMID: 39329969 PMC: 11431526. DOI: 10.3390/cimb46090617.

Transcriptome profiling of macrophages persistently infected with human respiratory syncytial virus and effect of recombinant calreticulin on immune-related genes.

Rivera-Toledo E, Fernandez-Rojas M, Santiago-Olivares C, Cruz-Rivera M, Hernandez-Bautista V, Avila-Horta F Front Microbiol. 2024; 15:1402589.

PMID: 39296294 PMC: 11408361. DOI: 10.3389/fmicb.2024.1402589.

Dampening of ISGylation of RIG-I by ADAP regulates type I interferon response of macrophages to RNA virus infection.

Wang Y, Feng H, Li X, Ruan Y, Guo Y, Cui X PLoS Pathog. 2024; 20(5):e1012230.

PMID: 38776321 PMC: 11111093. DOI: 10.1371/journal.ppat.1012230.

References

Fach S, Olivier A, Gallup J, Waters T, Ackermann M, Lehmkuhl H . Differential expression of cytokine transcripts in neonatal and adult ovine alveolar macrophages in response to respiratory syncytial virus or toll-like receptor ligation. Vet Immunol Immunopathol. 2010; 136(1-2):55-64. PMC: 2891083. DOI: 10.1016/j.vetimm.2010.02.008. View

Loebbermann J, Thornton H, Durant L, Sparwasser T, Webster K, Sprent J . Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol. 2012; 5(2):161-72. PMC: 3282434. DOI: 10.1038/mi.2011.62. View

Durbin R, Kotenko S, Durbin J . Interferon induction and function at the mucosal surface. Immunol Rev. 2013; 255(1):25-39. PMC: 5972370. DOI: 10.1111/imr.12101. View

Hussell T, Bell T . Alveolar macrophages: plasticity in a tissue-specific context. Nat Rev Immunol. 2014; 14(2):81-93. DOI: 10.1038/nri3600. View

Chang T, Segovia J, Sabbah A, Mgbemena V, Bose S . Cholesterol-rich lipid rafts are required for release of infectious human respiratory syncytial virus particles. Virology. 2011; 422(2):205-13. PMC: 3249476. DOI: 10.1016/j.virol.2011.10.029. View

Goritzka M, Durant L, Pereira C, Salek-Ardakani S, Openshaw P, Johansson C . Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection. J Virol. 2014; 88(11):6128-36. PMC: 4093897. DOI: 10.1128/JVI.00333-14. View

Pfortner C, Walter P, Steinmuller C, Lohmann-Matthes M, Kobzik L, Freihorst J . Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro. J Immunol. 1995; 154(1):268-80. View

Lifland A, Jung J, Alonas E, Zurla C, Crowe Jr J, Santangelo P . Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol. 2012; 86(15):8245-58. PMC: 3421640. DOI: 10.1128/JVI.00215-12. View

Minor R, Limmon G, Miller-DeGraff L, Dixon D, Andrews D, Kaufman R . Double-stranded RNA-activated protein kinase regulates early innate immune responses during respiratory syncytial virus infection. J Interferon Cytokine Res. 2009; 30(4):263-72. PMC: 3781957. DOI: 10.1089/jir.2009.0051. View

10.

Kipper S, Hamad S, Caly L, Avrahami D, Bacharach E, Jans D . New host factors important for respiratory syncytial virus (RSV) replication revealed by a novel microfluidics screen for interactors of matrix (M) protein. Mol Cell Proteomics. 2015; 14(3):532-43. PMC: 4349975. DOI: 10.1074/mcp.M114.044107. View

11.

Schneider C, Nobs S, Heer A, Kurrer M, Klinke G, van Rooijen N . Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection. PLoS Pathog. 2014; 10(4):e1004053. PMC: 3974877. DOI: 10.1371/journal.ppat.1004053. View

12.

Bajorek M, Caly L, Tran K, Maertens G, Tripp R, Bacharach E . The Thr205 phosphorylation site within respiratory syncytial virus matrix (M) protein modulates M oligomerization and virus production. J Virol. 2014; 88(11):6380-93. PMC: 4093874. DOI: 10.1128/JVI.03856-13. View

13.

Utley T, Ducharme N, Varthakavi V, Shepherd B, Santangelo P, Lindquist M . Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc Natl Acad Sci U S A. 2008; 105(29):10209-14. PMC: 2481327. DOI: 10.1073/pnas.0712144105. View

14.

Forster A, Maertens G, Farrell P, Bajorek M . Dimerization of matrix protein is required for budding of respiratory syncytial virus. J Virol. 2015; 89(8):4624-35. PMC: 4442381. DOI: 10.1128/JVI.03500-14. View

15.

McGillivary G, Jordan Z, Peeples M, Bakaletz L . Replication of respiratory syncytial virus is inhibited by the host defense molecule viperin. J Innate Immun. 2012; 5(1):60-71. PMC: 3595061. DOI: 10.1159/000342473. View

16.

Scott C, Henri S, Guilliams M . Mononuclear phagocytes of the intestine, the skin, and the lung. Immunol Rev. 2014; 262(1):9-24. DOI: 10.1111/imr.12220. View

17.

Goritzka M, Pereira C, Makris S, Durant L, Johansson C . T cell responses are elicited against Respiratory Syncytial Virus in the absence of signalling through TLRs, RLRs and IL-1R/IL-18R. Sci Rep. 2015; 5:18533. PMC: 4685246. DOI: 10.1038/srep18533. View

18.

Jumat M, Huong T, Ravi L, Stanford R, Tan B, Sugrue R . Viperin protein expression inhibits the late stage of respiratory syncytial virus morphogenesis. Antiviral Res. 2014; 114:11-20. DOI: 10.1016/j.antiviral.2014.11.007. View

19.

Kumagai Y, Takeuchi O, Kato H, Kumar H, Matsui K, Morii E . Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity. 2007; 27(2):240-52. DOI: 10.1016/j.immuni.2007.07.013. View

20.

Pribul P, Harker J, Wang B, Wang H, Tregoning J, Schwarze J . Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development. J Virol. 2008; 82(9):4441-8. PMC: 2293049. DOI: 10.1128/JVI.02541-07. View